About Ansana
Ansana is a company based in Amsterdam (Netherlands) founded in 2022. Ansana has raised $1.76 million across 1 funding round from investors including NLC Health Ventures, Healthliant Ventures and BGO Ventures. Ansana offers products and services including Smart Sterilization Device, Data Modules, and Reprocessing Services. Ansana operates in a competitive market with competitors including PuraCath Medical, Terragene, Bioquell, UVSmart and SteriLux, among others.
- Headquarter Amsterdam, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.76 M (USD)
in 1 rounds
-
Latest Funding Round
$1.76 M (USD), Seed
Sep 25, 2025
-
Investors
NLC Health Ventures
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ansana
Ansana offers a comprehensive portfolio of products and services, including Smart Sterilization Device, Data Modules, and Reprocessing Services.
Device for real-time tracking and sterilization of surgical instruments
Modules for quality release and inventory optimization in healthcare
Services for implementing and troubleshooting sterilization processes
Funding Insights of Ansana
Ansana has successfully raised a total of $1.76M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.76 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ansana
Ansana has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include NLC Health Ventures, Healthliant Ventures and BGO Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health innovations are found, built, and scaled by NLC.
|
Locked | Locked | Locked | |
|
Healthliant Ventures is focused on healthcare innovation and delivery.
|
Locked | Locked | Locked | |
|
Healthcare ventures are supported by BGO Ventures with investment and technology expertise.
|
Locked | Locked | Locked |
Investor details for Ansana
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ansana
Investment portfolio details for Ansana
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ansana
Detailed financials for Ansana
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ansana Comparisons
Peer comparison for Ansana
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ansana
Ansana operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PuraCath Medical, Terragene, Bioquell, UVSmart and SteriLux, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices are developed to reduce peritoneal dialysis infections.
|
|
| Locked | Locked | Locked |
Sterilization products and disinfection systems are supplied for workplaces.
|
|
| Locked | Locked | Locked |
Hydrogen Peroxide to decontaminate surfaces and medical equipment
|
|
| Locked | Locked | Locked |
Validated UV-C disinfection solutions are provided for healthcare environments.
|
|
| Locked | Locked | Locked |
Low-temperature ozone gas sterilization devices are developed by SteriLux.
|
|
| Locked | Locked | Locked |
Photoluminescent photocatalyst materials for air decontamination are supplied.
|
Detailed competitors of Ansana
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ansana
Complete news archive for Ansana
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ansana
Ansana was founded in 2022 and raised its 1st funding round 3 years after it was founded.
Ansana is headquartered in Amsterdam, Netherlands.
Dominique Surinx is the current CEO of Ansana.
Ansana is a funded company, having raised a total of $1.76M across 1 funding round to date.
Developer of sterilization devices for operating rooms and pharma companies. The company offers a smart sterilization container that is equipped with sensors that monitor the sterilization process and reduces surgical site infections, eliminating plastic consumables for hospitals.
Ansana's top competitors include Bioquell, PuraCath Medical and UVSmart.
Ansana offers Smart Sterilization Device, Data Modules, and Reprocessing Services.
Ansana has 3 investors. Key investors include NLC Health Ventures, Healthliant Ventures, and BGO Ventures.